NCT05280561View on ClinicalTrials.gov

Stress-induced Sleep Deficits and a Complementary Therapy

NACompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

July 25, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

November 3, 2022

Conditions
Insomnia Due to Anxiety and Fear
Interventions
DIETARY_SUPPLEMENT

DHM

DHM is a positive modulator of GABA. We hypothesize the DHM could reduce stress/anxiety induced insomnia during the pandemic

DIETARY_SUPPLEMENT

Placebo

Excipients including extracts of celery, strawberry, oranges, rose, and beet blended in powder form of 1 g

Trial Locations (1)

Unknown

Furise Group Co, Chengdu

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

University of Southern California

OTHER

NCT05280561 - Stress-induced Sleep Deficits and a Complementary Therapy | Biotech Hunter | Biotech Hunter